Skip to main content
Veterinary Medicines

Rabisin Injektionssuspension für Hunde, Katzen, Marderartige, Pferde, Rinder und Schafe

Authorised
  • Rabies virus, strain G52, Inactivated

Product identification

Medicine name:
Rabisin Injektionssuspension für Hunde, Katzen, Marderartige, Pferde, Rinder und Schafe
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Sheep
  • Cattle
  • Horse
  • Dog
  • Cat
  • Marten
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
    • Cat
    • Marten
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 94a/84
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 6/02/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."